Submit

News

LRF-funded Researcher’s Findings Published

                  Wei Du, M.D., Ph.D. and colleagues may have found a link between how stem cells make energy and Fanconi anemia, a disease that us usually diagnosed in children, who sometimes develop leukemia. Doctor Du’s findings could not only improve treatment but

Microscope Newsletter May 2019

Microscope Newsletter May 2019

LRF-funded Researcher Leads Team in Understanding Function of Rare Cells in Bone Marrow

                  Iannis Aifantis, Ph.D., professor and chair of the Department of Pathology at the Perlmutter Cancer Center at NYU Langone Health, and colleagues have discovered how rare blood cell types within the bone marrow microenvironment function. Understanding

Microscope Newsletter April 2019

Microscope Newsletter April 2019

LRF-funded Researcher Earns $1,187,006 Grant

                  Congratulations to Austin L. Brown, Ph.D., MPH for earning a 1,887,006 grant from the Cancer Prevention and Research Institute of Texas. Doctor Brown was funded by the Leukemia Research Foundation in 2017 for his research on acute lymphoblastic

Microscope Newsletter March 2019

Microscope Newsletter March 2019

Leukemia Research Foundation Earns Charity Navigator “4-Star Charity” Rating for the Third Time

(Northfield, Ill. – February 14, 2019) - The Leukemia Research Foundation proudly announces that for the third time in five years it has earned the coveted “4-Star Charity” rating from Charity Navigator, the highest possible rating from America’s largest national independent charity evaluator.

Microscope Newsletter February 2019

Microscope Newsletter February 2019

Super Heroes, Tommy Hawk and Therapy Dogs Highlight Party for Pediatric Blood Cancer Patients

Chicago Blackhawks mascot Tommy Hawk made a guest appearance at the Leukemia Research Foundation’s Kids’ Party. Patients were the superheroes at the Leukemia Research Foundation’s (LRF) Annual Kids’ Party. More than 120 guests including 35 pediatric patients enjoyed a fun morning filled with

LRF Medical Advisory Board Member and Patient Program Presenter Makes Key Finding on Newer CLL Medication

              Scott Smith, M.D., Ph.D. FACP is co-author of a study that found that a newer targeted medication called ibrutinib is more effective at treating chronic lymphocytic leukemia (CLL) in some patients than the current standard therapy. Read more about the finding